Benzinga | Aug 10, 2021 04:53PM EDT

Acer Therapeutics Q2 EPS $(0.23) Up From $(0.56) YoY

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.23) per share. This is a 58.93 percent increase over losses of $(0.56) per share from the same period last year.